Various alphabetized medical records

Life Sciences Commercial Disputes

New product introductions in the life sciences sector are frequently complex, costly, and time-consuming undertakings, and collaborations between companies are common. Disputes may arise at all stages of development and commercialization. Our expertise helps clients navigate litigated and arbitrated disputes involving drug development and commercialization and analyze relevant commercial factors (size of the opportunity, therapeutic area, business risks, etc.). CRA has provided expert reports and testimony evaluating development and commercialization efforts and assessing damages associated with alleged contractual breaches and other commercial issues.

Our focus areas


  • 01
    Commercial success of pre-operative skin sterilization products
    CRA was retained by the petitioner in an IPR proceeding at the Patent Trial and Appeal Board (PTAB) to determine whether there was evidence of commercial...
    View engagement
  • 02
    CRA consultants calculate damages in a false advertising matter under the Lanham Act
    CRA was retained by counsel for the plaintiff, a manufacturer of medical apparel, to determine damages relating to a false advertising matter under the Lanham...
    View engagement
  • 03
    CRA consultants support claims on abandoned generic collaboration
    Following an abandoned collaboration agreement between a complex peptide formulator and a generic manufacturer, CRA was retained to support an academic senior...
    View engagement

Subscribe to recieve our latest Insights.